会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NANOPARTICLES BASED ON A GAG AND A SQUALENE
    • 基于GAG和SQUALENE的纳米颗粒
    • WO2014091436A1
    • 2014-06-19
    • PCT/IB2013/060842
    • 2013-12-12
    • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEUNIVERSITE PARIS-SUD 11
    • RALAY-RANAIVO, BettinaCOUVREUR, PatrickDESMAELE, DidierBIANCHINI, ElsaBORGEL, DelphineGREF, Ruxandra
    • A61K47/48A61K31/727A61P7/02
    • A61K9/19A61K9/4891A61K9/5123A61K31/727A61K45/06A61K47/541A61K47/6907
    • The present invention relates to nanoparticles comprising at least one negatively charged glycosaminoglycan-type macromolecule or a derivative thereof, non-covalently coupled to at least one molecule of a cationic hydrocarbon-based radical of squalene nature represented by the formula (I) which follows: (I) wherein: A, B, C, D, E and F are a hydrogen atom or a methyl group; Z and Y represent a radical (formula (II)), an ethyltrialkylammonium radical, an ethylguanidium radical or a 1-[ethylideneamino]guanidinium radical with the proviso that at least one of Z and Y is different from (formula (II)), the symbol * showing the position of the attachment of the radical to the structure; and n is equal to 1 or 2. The present invention also relates to a method for preparing said nanoparticles, and to a lyophilisate, a solid dosage form and pharmaceutical or dermatological compositions comprising said nanoparticles. Said nanoparticles are useful as medicines and more particularly as anticoagulant agents.
    • 本发明涉及包含至少一种带负电荷的糖胺聚糖型大分子或其衍生物的纳米颗粒,所述至少一种带负电荷的糖胺聚糖型大分子或其衍生物与由下式(I)表示的角鲨烯性质的基于阳离子烃的基团的至少一个分子非共价偶联: (I)其中:A,B,C,D,E和F是氢原子或甲基; Z和Y代表一个基团(式(II)),乙基三烷基铵基,乙基胍基或1- [亚乙基氨基]胍基,条件是Z和Y中的至少一个不同于(式(II)), 符号*表示激进组织对结构的附着位置; 并且n等于1或2.本发明还涉及制备所述纳米颗粒的方法,还涉及冻干物,固体剂型和包含所述纳米颗粒的药物或皮肤病学组合物。 所述纳米颗粒可用作药物,更特别地可用作抗凝血剂。
    • 4. 发明申请
    • COLONIC DELIVERY OF ACTIVE AGENTS
    • 有效代理的殖民地交付
    • WO2006085075A2
    • 2006-08-17
    • PCT/GB2006/000448
    • 2006-02-09
    • DA VOLTERRACENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUESTEVENS, Ian, EdwardFATTAL, EliasANDREMONT, AntoineCOUVREUR, PatrickBOURGEOIS, Sandrine
    • FATTAL, EliasANDREMONT, AntoineCOUVREUR, PatrickBOURGEOIS, Sandrine
    • A61K9/1652A61K9/1682A61K31/155A61K38/465A61K38/47C12Y305/02006G01N2800/065
    • Drug delivery devices that are orally administered, and that release active ingredients in the colon, are disclosed. In one embodiment, the active ingredients are those that inactivate antibiotics, such as macrolides, quinolones and beta-lactam containing antibiotics. One example of a suitable active agent is an enzyme such as beta-lactamases. In another embodiment, the active agents are those that specifically treat colonic disorders, such as Chrohn's Disease, irritable bowel syndrome, ulcerative colitis, colorectal cancer or constipation. The drug delivery devices are in the form of beads of pectin, crosslinked with calcium and reticulated with polyethyleneimine. The high crosslink density of the polyethyleneimine is believed to stabilize the pectin beads for a sufficient amount of time such that a substantial amount of the active ingredients can be administered directly to the colon. Advantageously, the amount of polyethyleneimine is sufficient to allow a substantial portion of the pectin beads to pass through the gastrointestinal tract to the colon without releasing the active agent, and is also sufficient such that the pectin beads are sufficiently degraded in the colon to release an effective amount of the active agent.
    • 公开了口服给药并且释放结肠中活性成分的药物输送装置。 在一个实施方案中,活性成分是使抗生素失活的成分,例如大环内酯类,喹诺酮类和含β-内酰胺类的抗生素。 合适的活性剂的一个实例是酶如β-内酰胺酶。 在另一个实施方案中,活性剂是特异性治疗结肠疾病如克罗恩病,肠易激综合征,溃疡性结肠炎,结肠直肠癌或便秘的那些。 药物递送装置是果胶珠的形式,与钙交联并用聚乙烯亚胺网化。 据信聚乙烯亚胺的高交联密度使果胶珠稳定足够的时间,使得大量的活性成分可以直接施用于结肠。 有利地,聚乙烯亚胺的量足以使大部分果胶珠通过胃肠道进入结肠而不释放活性剂,并且也足够使得果胶珠在结肠中充分降解以释放 有效量的活性剂。